about
The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in miceHigh Mobility Group B Proteins, Their Partners, and Other Redox Sensors in Ovarian and Prostate CancerGenomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate CancerProstate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysisCyclooxygenase in the treatment of glioma: its complex role in signal transductionCOX2 genetic variation, NSAIDs, and advanced prostate cancer riskMiRNA-26b regulates the expression of cyclooxygenase-2 in desferrioxamine-treated CNE cellsHexavalent chromium Cr(VI) up-regulates COX-2 expression through an NFκB/c-Jun/AP-1-dependent pathwayUse of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control studyCOX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.Antibiotic and anti-inflammatory use and the risk of prostate cancerMolecular fingerprinting of radiation resistant tumors: can we apprehend and rehabilitate the suspects?Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis.Prostaglandin E2 modifies SMAD2 and promotes SMAD2-SMAD4 complex formation.Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC.Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progressionSelective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment.Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study.Meta-analysis of the association between COX-2 polymorphisms and risk of colorectal cancer based on case-control studies.New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system.Molecular biological design of novel antineoplastic therapies.Role of COX-2 inhibitors in cancer therapy.α(V)β(6) integrin expression is induced in the POET and Pten(pc-/-) mouse models of prostatic inflammation and prostatic adenocarcinoma.Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.Tissue biomarkers for prostate cancer radiation therapy.Current and future status of prostate cancer chemoprevention.Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis.COX-2 inhibition: a possible role in the management of prostate cancer?Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironmentThe association between regular use of aspirin and the prevalence of prostate cancer: Results from the National Health Interview SurveyRoles of Eicosanoids in Prostate Cancer.Cyclooxygenase inhibitors: scope of their use and development in cancer chemotherapy.Possible benefits of curcumin regimen in combination with taxane chemotherapy for hormone-refractory prostate cancer treatment.Saturated fatty acids up-regulate COX-2 expression in prostate epithelial cells via toll-like receptor 4/NF-κB signaling.Selective COX-2 inhibitor (celecoxib) decreases cellular growth in prostate cancer cell lines independent of p53.Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine.Synergistic antiproliferative and apoptotic effects induced by mixed epidermal growth factor receptor inhibitor ZD1839 and nitric oxide donor in human prostatic cancer cell lines.Down-regulation of cyclooxygenase-2 expression but up-regulation of cyclooxygenase-1 in renal carcinomas of the Eker (TSC2 gene mutant) rat model.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.
P2860
Q25255790-91EF3A13-4FF0-4CB5-88ED-1EC50D88F70BQ26774902-38F14560-D027-4BEF-A7FC-E926BCCEE7B7Q26778586-BEC23D19-878F-477F-A780-68EE6BDD1F5EQ28166676-CBB59B23-57A0-4ABE-BF94-C34C44E3DA1AQ28168685-B5B7788B-915D-4DDE-ADEC-6F860873D89CQ28217972-6A5505BD-A6BD-40EC-8191-DE1AEBB5FC9BQ28271329-A96CFC17-A403-4C75-8091-A3365F124638Q28383878-00DB9ACE-44F7-4DE7-A189-913DBB985793Q28476849-40ABF94B-6540-4C4C-8253-D46B3BE575CFQ31130013-A0FF28F4-64CB-4399-BAA2-A404060FA831Q33431458-DE945C91-2B8A-4465-A291-4A0D3D8327D2Q33480331-25E01B97-0BE9-43AF-898D-7D43F72E5DDBQ33614082-2E68E63B-D9B8-4698-81A1-5CACE179C18EQ33676062-4A519C80-CA84-4A43-81B4-7EB7FEA8BF3AQ34003141-0AC5FAD7-3AFD-443E-95E5-6FA6B61B3D63Q34014610-7FDFEA59-ED66-4880-9EA0-E0189FBEA13CQ35043366-B7B696BB-6EE8-42BE-877B-FFA7E73F9804Q35102355-8583F089-2552-4B1E-98EA-58E4A846DE56Q35147941-A644CBCA-1F05-44F1-8D97-50AB1BF5FDFDQ35149046-E758162E-B1B5-46D0-A1F6-F6433EB27B10Q35790781-6A609325-E32F-4D09-A2C2-974AFD9C7D59Q35806751-E52445B1-7537-4238-BCE2-C1782801447FQ35964178-BFE3E110-F313-411F-BC60-E9EE5FB904E0Q36129601-BDD38C29-7C3E-4888-9290-E695B06AC544Q36141341-E6B93822-0504-40D6-8DB6-0778C8F53A79Q36352079-02CE0BA5-A3E0-4C81-93C3-8A46684D04E8Q36629420-909C0A4D-7B3E-479C-A313-278E503D1FB7Q36740041-04C482E2-004F-4770-B160-1F6D622DEF3FQ36817810-0369A7A2-889A-4A0E-814B-40B1644F960FQ37205121-4FCC7404-B571-4A05-9519-B6D1BCDA6B65Q37592857-B45429DA-3297-44ED-8E25-F22EBB0723FFQ37646513-56D61474-F9CD-4DC8-B688-CF2B4D72A527Q37680771-B0A7D13D-7B0A-4AFB-AE1C-A25C9C7FCECDQ39063862-FB7E1233-1071-4E05-8E5E-FD5C48684BAFQ39241785-EDD246A9-2957-4DD0-8E55-1AE94DD11A0CQ39946879-F0F5DD05-514D-4CFC-9399-A8FCFEFA8F99Q40046885-49CFA470-3548-431E-97A4-1135606659E9Q40511482-4E230090-B3CB-42A0-9531-F5D9AEBC350BQ40653146-2272DCF8-7186-4F22-AF66-FD1FCC01EC8BQ42184292-B7EC96E9-93E3-4BCD-8D65-87B927446952
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of cyclooxygenase-2 in prostate cancer.
@ast
The role of cyclooxygenase-2 in prostate cancer.
@en
The role of cyclooxygenase-2 in prostate cancer.
@nl
type
label
The role of cyclooxygenase-2 in prostate cancer.
@ast
The role of cyclooxygenase-2 in prostate cancer.
@en
The role of cyclooxygenase-2 in prostate cancer.
@nl
prefLabel
The role of cyclooxygenase-2 in prostate cancer.
@ast
The role of cyclooxygenase-2 in prostate cancer.
@en
The role of cyclooxygenase-2 in prostate cancer.
@nl
P2093
P1433
P1476
The role of cyclooxygenase-2 in prostate cancer.
@en
P2093
P304
P356
10.1016/S0090-4295(01)01255-9
P407
P433
P577
2001-08-01T00:00:00Z